fda approved tirzepatide confirms shortage is still over, gives compounders a grace period FDA approves new obesity drug

Have a BMI of 27 or Higher with Weight-Related Health Problems Some people qualify for treatment with a BMI of 27 or higher, as long as they have health issues related to their weight

The trials studied it as a standalone

The most effective approaches include cognitive behavioural therapy (CBT), medication (typically SSRIs or SNRIs), or a combination of both

As tirzepatide clears over 3-4 weeks, gastrointestinal symptoms typically improve gradually, appetite may return, and blood glucose levels may rise in patients with diabetes

Mochi splits clinical care ($79/month membership) from drug cost ($229-$439/month for tirzepatide)

What if my doctor refuses to order the tests I need